CVE-2026-35653OpenClaw before 2026.3.24 contains an incorrect authorization vulnerability in the POST /reset-profile endpoint that allows authenticated callers with operator.write access to browser.request to bypa…
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw before 2026.3.24 contains an incorrect authorization vulnerability in the POST /reset-profile endpoint that allows authenticated callers with operator.write access to browser.request to bypass profile mutation restrictions. Attackers can invoke POST /reset-profile through the browser.request surface to stop the running browser, close Playwright connections, and move profile directories to Trash, crossing intended privilege boundaries.
- CVSS
- 8.1 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
- Weakness (CWE)
- CWE-863
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | before 2026.3.24 | NVD |
References
- https://github.com/openclaw/openclaw/commit/4dcc39c25c6cc63fedfd004f52d173716576fcf0patch
- https://github.com/openclaw/openclaw/commit/e7d11f6c33e223a0dd8a21cfe01076bd76cef87aexploit, mitigation, vendor-advisory
- https://github.com/openclaw/openclaw/security/advisories/GHSA-xp9r-prpg-373rexploit, mitigation, vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-incorrect-authorization-in-post-reset-profile-via-browser-requestthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.